Experience

Genetic SpA

• Pharmaceutical Manufacturing
• 100 - 200 Employee

• R&D Analyst

  • Mar 2021 - Present

  Literature searching; development and validation of analytical methods; product validation process; stability studies according to the ICH Q1A (R2) guideline; forced degradation studies; in vitro analysis to assess pMDI performance (DUSA, NGI, etc.); writing of protocols and reports. Ability to do presentation to discuss projects and data. Ability to manage people. Ability to use HPLC, UV, IR, NGI, DUSA, Karl Fischer titrator, Coulometric titrator, Osmometer, LC-MS, GC. Literature searching; development and validation of analytical methods; product validation process; stability studies according to the ICH Q1A (R2) guideline; forced degradation studies; in vitro analysis to assess pMDI performance (DUSA, NGI, etc.); writing of protocols and reports. Ability to do presentation to discuss projects and data. Ability to manage people. Ability to use HPLC, UV, IR, NGI, DUSA, Karl Fischer titrator, Coulometric titrator, Osmometer, LC-MS, GC.



Università degli Studi di Napoli Federico II

• Italy
• Higher Education
• 700 & Above Employee

• Industrial PhD Student in Pharmaceutical Science

  • Jan 2018 - Feb 2021

  - Ability in literature searching. - Ability to design novel synthetic pathways and to develop innovative chemical approches. - Ability in pharmaceutical synthesis of organic compounds and liquid and solid-phase synthesis of peptides. - Ability in purification and characterization of synthetized compouds. - Knowledges: Microwave-assisted synthesis, HPLC, NMR, ESI-MS, chromatography, SciFinder, PubMed. - Ability to do report or presentation of data and results. - Ability to manage master students. -Ability to organize training for master students. Show less



Genetic SpA

• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Visiting PhD Student

  • Jun 2020 - Nov 2020

  Training on development of different pharmaceutical forms, including the development of analytical methods and their validation, thus the validation processes and finally the stability studies to ensure the safety, efficacy, and quality of the new drugs, and to determinate its shelf-life. Training on the use of instruments in the R&D labs. Performing of stability studies of uniquedose and multidose eye drops, nebuliser suspension and pMDI. Training on development of different pharmaceutical forms, including the development of analytical methods and their validation, thus the validation processes and finally the stability studies to ensure the safety, efficacy, and quality of the new drugs, and to determinate its shelf-life. Training on the use of instruments in the R&D labs. Performing of stability studies of uniquedose and multidose eye drops, nebuliser suspension and pMDI.



Paris Lodron Universität Salzburg

• Austria
• Higher Education
• 400 - 500 Employee

• Visiting PhD Student

  • Feb 2019 - Aug 2019

  Solid-phase synthesis (both manually and automatic) and characterization (MALDI-TOF mass spectrometry, HPLC) of peptides. Structural analysis of peptides by UV, Circular Dichroism and 2D-NMR spectroscopy. Solid-phase synthesis (both manually and automatic) and characterization (MALDI-TOF mass spectrometry, HPLC) of peptides. Structural analysis of peptides by UV, Circular Dichroism and 2D-NMR spectroscopy.